CA3242451A1 - An injectable pharmaceutical composition for the treatment of respiratory diseases in animals - Google Patents
An injectable pharmaceutical composition for the treatment of respiratory diseases in animalsInfo
- Publication number
- CA3242451A1 CA3242451A1 CA3242451A CA3242451A CA3242451A1 CA 3242451 A1 CA3242451 A1 CA 3242451A1 CA 3242451 A CA3242451 A CA 3242451A CA 3242451 A CA3242451 A CA 3242451A CA 3242451 A1 CA3242451 A1 CA 3242451A1
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical composition
- injectable pharmaceutical
- animals
- treatment
- respiratory diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217704.2 | 2021-12-24 | ||
| EP21217704 | 2021-12-24 | ||
| PCT/EP2022/087700 WO2023118557A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3242451A1 true CA3242451A1 (en) | 2023-06-29 |
Family
ID=79601675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3242451A Pending CA3242451A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250057790A1 (https=) |
| EP (1) | EP4452226A1 (https=) |
| JP (1) | JP2024544415A (https=) |
| CN (1) | CN118632684A (https=) |
| AR (1) | AR128074A1 (https=) |
| AU (1) | AU2022420882A1 (https=) |
| CA (1) | CA3242451A1 (https=) |
| MX (1) | MX2024007862A (https=) |
| WO (1) | WO2023118557A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| WO2025133098A2 (en) | 2023-12-21 | 2025-06-26 | Intervet International B.V. | Processes to make crystalline forms of (s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts |
| WO2025133088A1 (en) | 2023-12-21 | 2025-06-26 | Intervet International B.V. | Crystalline forms of(s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
| BR112019012861A2 (pt) | 2016-12-23 | 2019-12-10 | Intervet Int Bv | compostos para o tratamento de doença respiratória bovina ou suína |
-
2022
- 2022-12-22 AR ARP220103558A patent/AR128074A1/es unknown
- 2022-12-23 EP EP22844124.2A patent/EP4452226A1/en active Pending
- 2022-12-23 CN CN202280085114.3A patent/CN118632684A/zh active Pending
- 2022-12-23 JP JP2024537407A patent/JP2024544415A/ja active Pending
- 2022-12-23 CA CA3242451A patent/CA3242451A1/en active Pending
- 2022-12-23 WO PCT/EP2022/087700 patent/WO2023118557A1/en not_active Ceased
- 2022-12-23 MX MX2024007862A patent/MX2024007862A/es unknown
- 2022-12-23 AU AU2022420882A patent/AU2022420882A1/en active Pending
- 2022-12-23 US US18/721,947 patent/US20250057790A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023118557A1 (en) | 2023-06-29 |
| MX2024007862A (es) | 2024-07-09 |
| CN118632684A (zh) | 2024-09-10 |
| AR128074A1 (es) | 2024-03-20 |
| AU2022420882A1 (en) | 2024-06-20 |
| JP2024544415A (ja) | 2024-11-29 |
| EP4452226A1 (en) | 2024-10-30 |
| US20250057790A1 (en) | 2025-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3242451A1 (en) | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals | |
| GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
| JP2007500697A5 (https=) | ||
| BR0013010A (pt) | Formulação de cloreto de sódio de moxifloxacina | |
| EP0820281B1 (en) | A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses | |
| RU2414902C1 (ru) | Бактерицидная композиция для профилактики и лечения инфекционных заболеваний копыт у животных | |
| SE9901573D0 (sv) | New compounds | |
| WO1991002529A2 (en) | Product and method for killing abnormal vertebrate cells | |
| Adegbeye et al. | Potential of silver nanoparticles for veterinary applications in livestock performance and health | |
| RU2107502C1 (ru) | Ветеринарный препарат, обладающий широким спектром действия, - йод однохлористый | |
| JP2013539466A5 (https=) | ||
| CA2386685A1 (en) | Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases | |
| AU5643299A (en) | Humic acid and its use in the treatment of various conditions | |
| EP2250887B1 (en) | Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins | |
| KR100227125B1 (ko) | 미포자충감염을치료하기위한벤즈이미다졸구충제의용도 | |
| CN114712355B (zh) | Rhps4在制备抑制金黄色葡萄球菌和铜绿假单胞菌药物中的应用 | |
| RU2203035C1 (ru) | Фармацевтическая композиция с дезинфицирующими, спороцидными и ранозаживляющими свойствами | |
| EP0992241A4 (en) | MEDICAL COMPOSITIONS AGAINST HELICOBACTER PYLORI | |
| AU4519189A (en) | Medicaments for the treatment of toxoplasmosis | |
| RU2083207C1 (ru) | Способ лечения экспериментального сапа у золотистых хомячков | |
| RU2005140156A (ru) | Применение аивлозина для лечения болезней, вызванных brachyspira pilosicoli или ornithobacterium rhinotracheale | |
| PT1059845E (pt) | Composicao fungicida compreendendo uma benzoilfenilureia | |
| RU1818095C (ru) | Препарат дл профилактики и лечени бронхопневмании сельскохоз йственных животных | |
| US20240374535A1 (en) | Compositions and methods for treating biofilm disorders and infections | |
| SU1629062A1 (ru) | Способ лечени колибактериоза тел т |